BRAZILIAN RARE EARTHS LIMITED (BRE)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

BRE

BRE - BRAZILIAN RARE EARTHS LIMITED

FNArena Sector : Rare Earth Minerals
Year End: December
GICS Industry Group : Materials
Debt/EBITDA: -0.03
Index: ASX300 | ALL-ORDS

0

LAST PRICE CHANGE +/- CHANGE % VOLUME

$3.22

08 Oct
2026

-0.110

OPEN

$3.30

-3.30%

HIGH

$3.31

690,740

LOW

$3.14

TARGET
$6.50 101.9% upside
OTHER COMPANIES IN THE SAME SECTOR
ARU . HAS . LIN . LYC . MEI . MTM . NTU . SGQ . SVM . VHM . VML . VMM .
FNARENA'S MARKET CONSENSUS FORECASTS
BRE: 1
Title FY24
Actual
FY25
Actual
FY26
Forecast
FY27
Forecast
EPS (cps) xxx - 0.0 - 21.4 xxx
DPS (cps) xxx 0.0 0.0 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A N/A xxx
Dividend Yield xxx N/A 0.0% xxx
Div Pay Ratio(%) xxx N/A N/A xxx

Dividend yield today if purchased 3 years ago: N/A

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

0.00

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

$ 

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross
Cash & Equivalents - Generic
Price To Book Value

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development
Investments - Total

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Ord Minnett

31/08/2026

1

Speculative Buy

$6.50

101.86%

Brazilian Rare Earths' 1H26 results were largely in line with Ord Minnett's expectations, given reiteration of information previously disclosed in the June quarterly and subsequent Monte Alto Scoping Study.

The company's $134m cash balance is expected to fund exploration through 2028 as attention shifts towards permitting and development of the Monte Alto project.

Ord Minnett highlights Monte Alto's potential scale, with the Scoping Study outlining average annual production over the first five years of around 6.4kt of NdPr oxide and 2.5kt of heavy rare earth concentrate.

The broker retains its $6.50 target and Speculative Buy rating.

FORECAST
Ord Minnett forecasts a full year FY26 dividend of 0.00 cents and EPS of minus -21.40 cents.
Ord Minnett forecasts a full year FY27 dividend of 0.00 cents and EPS of minus -14.70 cents.

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

2

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Canaccord Genuity

xx/xx/xxxx

1

xxxxxxxxxxx xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Argonaut

01/04/2026

2

Speculative Buy

$5.80

80.12%

Argonaut maintains a Speculative Buy rating for Brazilian Rare Earths with a 5.80 target price following scoping study outcomes for the Amargosa Bauxite Project and a strategic downstream partnership.

The broker notes the Amargosa study outlines a low-capex, 17-year project generating average annual free cash flow of US$84m, which the company intends to spin out into a separate listed entity.

A recent 120m capital raising has bolstered the cash position to 162m, providing significant runway for development as rare earth production is not modeled until FY32.

Technical support from Processor Carester is seen as a key de-risking milestone for the Monte Alto project.

Future valuation remains tied to the successful commercialisation of the core rare earth assets, with the current price target reflecting a 50:50 blend of spot and forecast metal prices.

BRE STOCK CHART